相关实验视频
Updated: May 5, 2026
08:16
One-anastomosis Gastric Bypass OAGB in Rats
Published on: November 10, 2018
10.9K
肥胖症的内镜治疗:一个更新系统审查的协议与随机对照试验的网络元分析
Eun Jeong Gong1,2,3, Chang Seok Bang1,2,3, Gwang Ho Baik1,2
1Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea.
PloS one
|September 6, 2024
概括
这项研究更新了内镜减肥治疗 (EBT) 的系统审查和网络元分析,以比较其疗效. 这些发现将指导医生选择最佳的肥胖治疗方法,以获得更好的患者结果.
科学领域:
- 医疗技术 医疗技术 医学技术
- 胃肠病学 胃肠病学
- 公共卫生 公共卫生
背景情况:
- 肥胖是一个全球性的健康挑战,需要有效的干预措施.
- 内镜减肥治疗 (EBT) 为传统的肥胖管理提供了新的替代方案.
- 现有审查显示不同EBT之间的结果差异,需要更新分析.
研究的目的:
- 对EBT进行随机对照试验 (RCT) 的更新系统审查和网络元分析.
- 透明地呈现EBT疗效研究中的可复制性协议.
- 为各种EBT提供比较的疗效数据.
主要方法:
- 在PROSPERO (CRD42024514249) 上注册的RCT的系统审查和网络元分析.
- 搜索MEDLINE,Embase和Cochrane图书馆,由两个评估员进行独立选.
- 包括RCT报告6个月以上的随访后体重减轻或体重总减轻的百分比;使用Cochrane风险偏差工具 (ROB 2.0) 进行评估.
主要成果:
- 主要结局是至少6个月的随访后,百分比的多余体重减轻或百分比的总体重减轻.
- 数据综合将是叙事或定量基于研究的同质性.
- 研究质量将使用Cochrane风险偏差工具版本2.0.0进行评估.
结论:
- 这一更新的元分析将为各种EBT提供比较的疗效数据.
- 这些发现将有助于临床医生选择最有效的肥胖治疗策略.
- 提高EBT研究的透明度和可重复性是优先考虑的.
相关概念视频
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
445
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
445
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
330
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
330